137 related items for PubMed ID: 2635222
1. Evening urine cortisol excretion and DST results in depression and anorexia nervosa.
Zis AP, Remick RA, Clark CM, Goldner EM, Grant BE, Bernstein M.
J Psychiatr Res; 1989; 23(3-4):251-5. PubMed ID: 2635222
[Abstract] [Full Text] [Related]
2. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
[Abstract] [Full Text] [Related]
3. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol.
Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G, Zappulli D, Cavagnini F.
Eur J Endocrinol; 2001 Aug 15; 145(2):165-71. PubMed ID: 11454512
[Abstract] [Full Text] [Related]
4. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL.
Arch Gen Psychiatry; 1987 Apr 15; 44(4):328-36. PubMed ID: 3566455
[Abstract] [Full Text] [Related]
5. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
Schweitzer I, Tuckwell VM, Maguire KP, Tiller JW, Harrison LC, Davies BM.
Psychoneuroendocrinology; 1991 Apr 15; 16(5):375-82. PubMed ID: 1805291
[Abstract] [Full Text] [Related]
6. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
Tajima-Pozo K, Montes-Montero A, Güemes I, González-Vives S, Díaz-Marsá M, Carrasco JL.
Endocrinol Nutr; 2013 Apr 15; 60(7):396-403. PubMed ID: 23623464
[Abstract] [Full Text] [Related]
7. Basal activity of the hypothalamic-pituitary-adrenal axis and cognitive function in anorexia nervosa.
Seed JA, Dixon RA, McCluskey SE, Young AH.
Eur Arch Psychiatry Clin Neurosci; 2000 Apr 15; 250(1):11-5. PubMed ID: 10738859
[Abstract] [Full Text] [Related]
8. Cortisol escape from suppression by dexamethasone during depression is strongly predicted by basal cortisol hypersecretion and increasing age combined.
Maes M, Minner B, Suy E, D'Hondt P, Jacobs MP, Raus J.
Psychoneuroendocrinology; 1991 Apr 15; 16(4):295-310. PubMed ID: 1745698
[Abstract] [Full Text] [Related]
9. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
Arch Gen Psychiatry; 1984 Mar 15; 41(3):257-67. PubMed ID: 6367690
[Abstract] [Full Text] [Related]
10. The dexamethasone suppression test and pituitary-adrenocortical function.
Brown WA, Keitner G, Qualls CB, Haier R.
Arch Gen Psychiatry; 1985 Feb 15; 42(2):121-3. PubMed ID: 3977539
[Abstract] [Full Text] [Related]
11. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
Thompson LM, Rubin RT, McCracken JT.
Psychoneuroendocrinology; 1992 Oct 15; 17(5):507-15. PubMed ID: 1484917
[Abstract] [Full Text] [Related]
12. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
Pfohl B, Sherman B, Schlechte J, Stone R.
Arch Gen Psychiatry; 1985 Sep 15; 42(9):897-903. PubMed ID: 2994590
[Abstract] [Full Text] [Related]
13. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
Holsboer F, Gerken A, Steiger A, Fass V.
Acta Psychiatr Scand; 1984 May 15; 69(5):383-90. PubMed ID: 6730994
[Abstract] [Full Text] [Related]
14. Major depressive episode and low dose dexamethasone suppression test.
Sarai M, Taniguchi N, Kagomoto T, Kameda H, Uema T, Hishikawa Y.
Folia Psychiatr Neurol Jpn; 1982 May 15; 36(2):109-14. PubMed ID: 7129257
[Abstract] [Full Text] [Related]
15. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
Hudson JI, Pope HG, Jonas JM, Laffer PS, Hudson MS, Melby JC.
Psychiatry Res; 1983 Feb 15; 8(2):111-7. PubMed ID: 6574529
[Abstract] [Full Text] [Related]
16. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.
Axelson DA, Doraiswamy PM, Boyko OB, Rodrigo Escalona P, McDonald WM, Ritchie JC, Patterson LJ, Ellinwood EH, Nemeroff CB, Krishnan KR.
Psychiatry Res; 1992 Oct 15; 44(1):63-70. PubMed ID: 1461948
[Abstract] [Full Text] [Related]
17. [Dexamethasone suppression test in anorexia nervosa].
Kuhs H, Mester H.
Eur Arch Psychiatry Neurol Sci; 1985 Oct 15; 234(5):335-40. PubMed ID: 3987742
[Abstract] [Full Text] [Related]
18. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
Arch Gen Psychiatry; 1987 Sep 15; 44(9):790-5. PubMed ID: 3632252
[Abstract] [Full Text] [Related]
19. Dexamethasone suppression test in diagnosis of depressive illness.
Hayes PE, Ettigi P.
Clin Pharm; 1983 Sep 15; 2(6):538-45. PubMed ID: 6140096
[Abstract] [Full Text] [Related]
20. The hypothalamic-pituitary-adrenal system in panic disorder.
Goldstein S, Halbreich U, Asnis G, Endicott J, Alvir J.
Am J Psychiatry; 1987 Oct 15; 144(10):1320-3. PubMed ID: 3661766
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
